Lung transplantation and end of life issues in cystic fibrosis

P Aurora1, I M Lynn

  • 1Department of Paediatric Respiratory Medicine, Royal Brompton and Harefield NHS Trust, London, UK. paulaurora@yahoo.co.uk

Insights

Lung transplantation for cystic fibrosis lung disease has poor outcomes and limited organ supply. Some children choose medical management and terminal care over this option.

Area of Science:

  • Pulmonology
  • Transplant Surgery
  • Pediatric Care

Background:

  • Lung transplantation is a treatment option for end-stage cystic fibrosis lung disease.
  • Outcomes remain suboptimal, and donor organ availability is restricted.
  • This influences treatment decisions for pediatric patients.

Purpose of the Study:

  • To review the current landscape of lung transplantation for cystic fibrosis.
  • To outline current referral guidelines and contraindications for lung transplantation.
  • To discuss contemporary practices in terminal care for these patients.

Main Methods:

  • Literature review of lung transplantation in cystic fibrosis.
  • Analysis of current referral criteria and contraindications.
  • Examination of terminal care protocols.

Main Results:

  • Lung transplantation for cystic fibrosis has historically yielded poor results.
  • Limited organ availability is a significant barrier to transplantation.
  • Alternative management, including terminal care, is a consideration for some patients.

Conclusions:

  • Lung transplantation for cystic fibrosis remains challenging due to outcomes and organ scarcity.
  • Careful consideration of referral guidelines and contraindications is essential.
  • Terminal care represents a valid alternative pathway for select pediatric patients.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...